Elevai Labs, Financials
| ELAB Stock | 2.05 0.36 14.94% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.94 | 3.7919 |
|
|
Investors should never underestimate Elevai Labs,'s ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Elevai Labs,'s cash flow, debt, and profitability to make informed and accurate decisions about investing in Elevai Labs, Common.
Net Income |
|
Elevai | Select Account or Indicator |
Understanding current and past Elevai Labs, Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Elevai Labs,'s financial statements are interrelated, with each one affecting the others. For example, an increase in Elevai Labs,'s assets may result in an increase in income on the income statement.
Please note, the presentation of Elevai Labs,'s financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Elevai Labs,'s management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Elevai Labs,'s management manipulating its earnings.
Elevai Labs, Stock Summary
Elevai Labs, competes with ATRenew, Cedar Realty, Kite Realty, Tradeweb Markets, and National Vision. Elevai Labs, is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 28622K104 |
| Location | California; U.S.A |
| Business Address | 120 Newport Center |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | elevaiskincare.com |
| Phone | 866 794 4940 |
Elevai Labs, Key Financial Ratios
| Return On Equity | -3.51 | ||||
| Profit Margin | (1.92) % | ||||
| Operating Margin | (2.32) % | ||||
| Price To Sales | 2.99 X | ||||
| Revenue | 1.71 M |
Elevai Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Elevai Labs,'s current stock value. Our valuation model uses many indicators to compare Elevai Labs, value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Elevai Labs, competition to find correlations between indicators driving Elevai Labs,'s intrinsic value. More Info.Elevai Labs, Common is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . At present, Elevai Labs,'s Return On Equity is projected to drop based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Elevai Labs,'s earnings, one of the primary drivers of an investment's value.Elevai Labs, Common Systematic Risk
Elevai Labs,'s systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Elevai Labs, volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Elevai Labs, Common correlated with the market. If Beta is less than 0 Elevai Labs, generally moves in the opposite direction as compared to the market. If Elevai Labs, Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Elevai Labs, Common is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Elevai Labs, is generally in the same direction as the market. If Beta > 1 Elevai Labs, moves generally in the same direction as, but more than the movement of the benchmark.
About Elevai Labs, Financials
What exactly are Elevai Labs, Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Elevai Labs,'s income statement, its balance sheet, and the statement of cash flows. Potential Elevai Labs, investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Elevai Labs, investors may use each financial statement separately, they are all related. The changes in Elevai Labs,'s assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Elevai Labs,'s income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Elevai Labs, Thematic Clasifications
Elevai Labs, Common is part of Pharmaceutical Products investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Pharmaceutical Products industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Pharmaceutical Products industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
| Pharmaceutical Products | View |
Today, most investors in Elevai Labs, Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Elevai Labs,'s growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Elevai Labs, growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Elevai Labs, December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Elevai Labs, help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Elevai Labs, Common. We use our internally-developed statistical techniques to arrive at the intrinsic value of Elevai Labs, Common based on widely used predictive technical indicators. In general, we focus on analyzing Elevai Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Elevai Labs,'s daily price indicators and compare them against related drivers.
| Information Ratio | (0.23) | |||
| Maximum Drawdown | 106.14 | |||
| Value At Risk | (31.03) | |||
| Potential Upside | 12.9 |
Complementary Tools for Elevai Stock analysis
When running Elevai Labs,'s price analysis, check to measure Elevai Labs,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevai Labs, is operating at the current time. Most of Elevai Labs,'s value examination focuses on studying past and present price action to predict the probability of Elevai Labs,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevai Labs,'s price. Additionally, you may evaluate how the addition of Elevai Labs, to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |